Inventor
MARTIN BOHLIN
Inventor
SE
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Bprimary
C07BGeneral methods of organic chemistry24%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07DHeterocyclic compounds17%
Y02ATechnologies for adaptation to climate change10%
C07KPeptides7%
Y02PClimate change mitigation technologies in the production or processing of goods7%
PatentTitleYear
12,508,234Pharmaceutical formulation of odevixibat202512,281,179Solution phase synthesis of b-turn peptidomimetic cyclic salts202512,091,394Crystal modifications of odevixibat202411,801,226Pharmaceutical formulation of odevixibat202311,802,115Pharmaceutical formulation of odevixibat202311,753,441Solution phase synthesis of beta-turn peptidomimetic cyclic salts202311,365,182Crystal modifications of odevixibat2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ALBIREO AB (5)· patent assignee history
2022–2025Based in SE· patent location history
2023–2025Patents assigned to MIMETOGEN PHARMACEUTICALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALBIREO AB | 5 | 2022–2025 |
| MIMETOGEN PHARMACEUTICALS INC | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| SE | 7 | 2022–2025 |